HUMAN CD5+ (B1) B-CELLS IN HEALTH AND DISEASE

被引:0
作者
LYDYARD, PM [1 ]
YOUINOU, PY [1 ]
机构
[1] BREST UNIV HOSP, SCH MED, IMMUNOL LAB, BREST, FRANCE
来源
FUNDAMENTAL AND CLINICAL IMMUNOLOGY | 1994年 / 2卷 / 01期
关键词
CD5; B-CELLS; B1-CELLS; NATURAL ANTIBODIES; CLL; AUTOIMMUNE DISEASES;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD5 B cells (B1 cells) are the first B cells to be produced during ontogeny and usually utilise minimally mutated germ-line genes. They are mainly of the IgM class but may also express IgG and IgA. They produce low avidity auto and polyreactive antibodies (natural antibodies). There is evidence for and against B1 cells being a separate lineage. B1 cells probably play a role in setting up the idiotype network, antigen presentation and tolerance induction. Their relative importance of each of these different functions in maintaining an effective normal immune system is unclear. Chronic lymphocytic leukemia is a malignancy of the B1 population and Rheumatoid Arthritis probabLy represents an abnormal antigen-driven maturation of specific self-reactive anti-IgGFc clones. Since B1 cells are regulated by cytokines, other autoimmune diseases including some organ specific diseases where there is an increase in CD5 B cells, may represent abnormal cytokine regulation.
引用
收藏
页码:9 / 25
页数:17
相关论文
共 207 条
  • [11] BATATA A, 1993, CANCER, V71, P2732, DOI 10.1002/1097-0142(19930501)71:9<2732::AID-CNCR2820710908>3.0.CO
  • [12] 2-Z
  • [13] RELATIONSHIP BETWEEN CD5+ LYMPHOCYTES-B AND THE ACTIVITY OF SYSTEMIC AUTOIMMUNITY
    BECKER, H
    WEBER, C
    STORCH, S
    FEDERLIN, K
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1990, 56 (02): : 219 - 225
  • [14] ANTI-MAC-1 SELECTIVELY INHIBITS THE MOUSE AND HUMAN TYPE 3 COMPLEMENT RECEPTOR
    BELLER, DI
    SPRINGER, TA
    SCHREIBER, RD
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 156 (04) : 1000 - 1009
  • [15] CD5 AND CD21 MOLECULES ARE A FUNCTIONAL UNIT IN THE CELL SUBSTRATE ADHESION OF B-CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS
    BERGUI, L
    TESIO, L
    SCHENA, M
    RIVA, M
    MALAVASI, F
    SCHULZ, T
    MARCHISIO, PC
    CALIGARISCAPPIO, F
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (01) : 89 - 96
  • [16] CONTENT AND ORGANIZATION OF THE HUMAN IG VH LOCUS - DEFINITION OF 3 NEW VH FAMILIES AND LINKAGE TO THE IG CH LOCUS
    BERMAN, JE
    MELLIS, SJ
    POLLOCK, R
    SMITH, CL
    SUH, H
    HEINKE, B
    KOWAL, C
    SURTI, U
    CHESS, L
    CANTOR, CR
    ALT, FW
    [J]. EMBO JOURNAL, 1988, 7 (03) : 727 - 738
  • [17] FURTHER CHARACTERIZATION OF PROLYMPHOCYTIC LEUKEMIA-CELLS AS A TUMOR OF ACTIVATED B-CELLS
    BERREBI, A
    BASSOUSGUEDJ, L
    VORST, E
    DAGAN, S
    SHTALRID, M
    FREEDMAN, A
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1990, 34 (03) : 181 - 185
  • [18] LACK OF NATURAL ANTIBODIES IN RHEUMATIC DISEASES
    BIJLSMA, JWJ
    PLATERZYBERK, C
    MUMFORD, P
    MAINI, RN
    [J]. RHEUMATOLOGY INTERNATIONAL, 1990, 10 (03) : 107 - 112
  • [19] BIONDI A, 1989, BLOOD, V73, P1279
  • [20] WALDENSTROMS MACROGLOBULINEMIA AND AUTOIMMUNE-DISEASE IN A FAMILY
    BLATTNER, WA
    GARBER, JE
    MANN, DL
    MCKEEN, EA
    HENSON, R
    MCGUIRE, DB
    FISHER, WB
    BAUMAN, AW
    GOLDIN, LR
    FRAUMENI, JF
    [J]. ANNALS OF INTERNAL MEDICINE, 1980, 93 (06) : 830 - 832